| Platelet receptors and signaling in the dynamics of thrombus formation J Rivera, ML Lozano, L Navarro-Núñez, V Vicente haematologica 94 (5), 700, 2009 | 547 | 2009 |
| Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells DA Cheresh, SA Berliner, V Vicente, ZM Ruggeri Cell 58 (5), 945-953, 1989 | 456 | 1989 |
| Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera A Alvarez-Larrán, A Pereira, F Cervantes, E Arellano-Rodrigo, ... Blood, The Journal of the American Society of Hematology 119 (6), 1363-1369, 2012 | 310 | 2012 |
| Polymorphisms of Platelet Membrane Glycoprotein Ib Associated With Arterial Thrombotic Disease R Gonzalez-Conejero, ML Lozano, J Rivera, J Corral, JA Iniesta, ... Blood, The Journal of the American Society of Hematology 92 (8), 2771-2776, 1998 | 288 | 1998 |
| Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia A Alvarez-Larrán, F Cervantes, A Pereira, E Arellano-Rodrigo, ... Blood, The Journal of the American Society of Hematology 116 (8), 1205-1210, 2010 | 284 | 2010 |
| Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a “real-world” population with atrial fibrillation receiving anticoagulant therapy V Roldán, F Marín, H Fernández, S Manzano-Fernandez, P Gallego, ... Chest 143 (1), 179-184, 2013 | 281 | 2013 |
| Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer E García-Martínez, GL Gil, AC Benito, E González-Billalabeitia, ... Breast cancer research 16, 1-17, 2014 | 274 | 2014 |
| Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time PM Mannucci, V Vicente, L Vianello, M Cattaneo, I Alberca, MP Coccato, ... | 271 | 1986 |
| The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial … V Roldán, F Marín, S Manzano-Fernández, P Gallego, JA Vílchez, ... Journal of the American College of Cardiology 62 (23), 2199-2204, 2013 | 248 | 2013 |
| Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor JA Guerrero, ML Lozano, J Castillo, O Benavente‐Garcia, V Vicente, ... Journal of Thrombosis and Haemostasis 3 (2), 369-376, 2005 | 248 | 2005 |
| Biological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure? R Gonzalez-Conejero, J Rivera, J Corral, C Acuna, JA Guerrero, ... Stroke 36 (2), 276-280, 2005 | 236 | 2005 |
| Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm S Gretarsdottir, AF Baas, G Thorleifsson, H Holm, M Den Heijer, ... Nature genetics 42 (8), 692-697, 2010 | 235 | 2010 |
| Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding. V Vicente, RA Houghten, ZM Ruggeri Journal of Biological Chemistry 265 (1), 274-280, 1990 | 231 | 1990 |
| Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation P Gallego, V Roldan, F Marín, M Romera, M Valdés, V Vicente, GYH Lip Thrombosis and haemostasis 110 (12), 1189-1198, 2013 | 219 | 2013 |
| Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis MD Tabernero, JF Tomas, I Alberca, A Orfao, AL Borrasca, V Vicente American journal of hematology 36 (4), 249-254, 1991 | 191 | 1991 |
| Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation P Gallego, V Roldán, JM Torregrosa, J Gálvez, M Valdés, V Vicente, ... Circulation: Arrhythmia and Electrophysiology 5 (2), 312-318, 2012 | 189 | 2012 |
| Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients V Roldán, F Marín, B Muiña, JM Torregrosa, D Hernández-Romero, ... Journal of the American College of Cardiology 57 (25), 2496-2504, 2011 | 169 | 2011 |
| SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation P Gallego, V Roldán, F Marin, J Gálvez, M Valdés, V Vicente, GYH Lip The American journal of medicine 127 (11), 1083-1088, 2014 | 168 | 2014 |
| The FXIII Val34Leu polymorphism in venous and arterial thromboembolism J Corral, R González-Conejero, JA Iniesta, J Rivera, C Martínez, ... Haematologica 85 (3), 293-297, 2000 | 154 | 2000 |
| A multimarker risk stratification approach to non‐ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro‐BNP and fibrin D‐dimer levels A Tello‐Montoliu, F Marin, V Roldán, L Mainar, MT López, F Sogorb, ... Journal of internal medicine 262 (6), 651-658, 2007 | 151 | 2007 |
Javier CorralDepartamento de Medicina. Facultad de Medicina. Universidad de Murcia. IMIB. CIBERER-ISCIII在 um.es 的电子邮件经过验证
